Biography:
Dr. Wright completed an undergraduate degree in Biology from the University of Virginia in 1972, his M.D. degree from the University of Virginia in 1976, an internship in internal medicine at Columbia P&S Harlem Hospital in New York City in 1977. He then spent 3 years in the Army in Germany seeing patients before returning to the United States to complete a two residency in Internal Medicine, a 3 year research fellowship in Infectious Disease both at Walter Reed Army Medical Center in Washington D.C and tropical medicine training at Walter Reed Army Institute of Research. During his fellowship he set-up the first HIV-1 clinic in the military which he continued to run until 1988. He then left to cofound Univax Biologics, the third biotechnology company in Maryland. In 1993 he cofounded Novavax. Dr. Wight left Novavax in 2006. He has set-up 3 additional companies LPJP, Inc., David Craig Wright, M.D. Inc. (both California S corporations) and D4 Labs, LLC (California LLC). Dr. Wright has authored or co-authored over 20 issued US patents since 1989.
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
Title : Immunogenicity and efficacy of a subcutaneously administered, adjuvanted vaccine containing modified S1 spike protein of SARS-CoV-2 variant C.1.2
Title : Preparation, characterization, and stability of SubATVax™ adjuvanted commercial veterinary vaccines using six commercial vaccines, including rabies, leptospirosis and an encephalomyelitis combination vaccine for subcutaneous administration
Title : Preparation of SubATVax™ adjuvanted vaccines against inactivated poliovirus, diphtheria toxoid, tetanus toxoid, acellular pertussis, neisseria meningitidis, streptococcus pneumoniae, and haemophilus influenzae polysaccharide conjugates for subcutaneous administration